Table 1.
Total participants | n = 38 |
Total samples included in analysis | n = 36 |
Excluded samples | 2 |
Age (years; mean ± SD) | 53.4 ± 12.4 |
Gender (# and % of participants) | |
---|---|
Male | 19 (52.7%) |
Female | 17 (47.3%) |
Aged 61 and above (# of participants) | 16 |
Male | 7 |
Female | 9 |
Young 60 and below (# of participants) | 20 |
Male | 12 |
Female | 8 |
Aged- age range | 61 – 70 |
Median | 64.24 |
Young- age range | 27 – 60 |
Median | 45.55 |
Aged- severity range | 0 - 8 |
Median | 4 |
Young- severity range | 0 - 4 |
Median | 3 |
Aged-Number of patients with severe disease (Deceased) | 2 |
Young-Number of patients with severe disease (Deceased) | 0 |
Inclusion criteria | 1. Samples and data are contained within the UH Institutional COVID-19 and Coronavirus Biorepository 2. Age range: 18-89 3. Must be tested positive for SARS-CoV-2 RNA, as confirmed through RT-PCR of the nasopharyngeal swabs |
Exclusion criteria | Any sample or data not obtained in the UH Institutional COVID-19 and Coronavirus Biorepository |
Non-hospitalized/Ambulatory (%) | 30.5 |
Hospitalization (%) | 69.4 |
For hospitalized-WHO disease severity scale* | 3, 4, and 8 |
Hospitalized without oxygen therapy (%) | 32 |
Hospitalized with oxygen therapy (%) | 60 |
Length of stay (LOS)-Hospitalization | |
(days; mean ± SD) | 7.6 ± 6.6 |
LOS (%; < 7 days) | 56 |
LOS (%; > 7 days) | 44 |